VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 115 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274 | -62.7% | 63,502 | -42.9% | 0.00% | -50.0% |
| Q2 2023 | $735 | +0.5% | 111,203 | +3.3% | 0.00% | 0.0% |
| Q1 2023 | $731 | -9.1% | 107,695 | -0.8% | 0.00% | 0.0% |
| Q4 2022 | $804 | -99.9% | 108,572 | +72.7% | 0.00% | 0.0% |
| Q3 2022 | $621,000 | +2.1% | 62,873 | +12.8% | 0.00% | 0.0% |
| Q2 2022 | $608,000 | +8.4% | 55,717 | +15.2% | 0.00% | +100.0% |
| Q1 2022 | $561,000 | -26.0% | 48,368 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $758,000 | -9.4% | 48,368 | -0.1% | 0.00% | 0.0% |
| Q3 2021 | $837,000 | -19.6% | 48,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,041,000 | +49.8% | 48,400 | +4.5% | 0.00% | 0.0% |
| Q1 2021 | $695,000 | -2.7% | 46,313 | -14.8% | 0.00% | +100.0% |
| Q4 2020 | $714,000 | +23.7% | 54,347 | -9.2% | 0.00% | 0.0% |
| Q3 2020 | $577,000 | -24.5% | 59,855 | -10.3% | 0.00% | -50.0% |
| Q2 2020 | $764,000 | +6.0% | 66,716 | -4.5% | 0.00% | 0.0% |
| Q1 2020 | $721,000 | -33.9% | 69,864 | +4.2% | 0.00% | 0.0% |
| Q4 2019 | $1,091,000 | +10.6% | 67,025 | -4.2% | 0.00% | 0.0% |
| Q2 2019 | $986,000 | -23.4% | 69,988 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $1,287,000 | -23.8% | 69,988 | 0.0% | 0.00% | -40.0% |
| Q4 2018 | $1,688,000 | +1064.1% | 69,988 | +1008.8% | 0.01% | – |
| Q3 2018 | $145,000 | +20.8% | 6,312 | 0.0% | 0.00% | – |
| Q2 2018 | $120,000 | -23.6% | 6,312 | -32.2% | 0.00% | – |
| Q1 2018 | $157,000 | +11.3% | 9,304 | 0.0% | 0.00% | – |
| Q4 2017 | $141,000 | +193.8% | 9,304 | +244.6% | 0.00% | – |
| Q3 2017 | $48,000 | +9.1% | 2,700 | 0.0% | 0.00% | – |
| Q2 2017 | $44,000 | +15.8% | 2,700 | 0.0% | 0.00% | – |
| Q1 2017 | $38,000 | -11.6% | 2,700 | 0.0% | 0.00% | – |
| Q4 2016 | $43,000 | -82.8% | 2,700 | -82.0% | 0.00% | – |
| Q3 2016 | $250,000 | +197.6% | 15,000 | +100.0% | 0.00% | – |
| Q2 2016 | $84,000 | +33.3% | 7,500 | 0.0% | 0.00% | – |
| Q1 2016 | $63,000 | -10.0% | 7,500 | 0.0% | 0.00% | – |
| Q4 2015 | $70,000 | -17.6% | 7,500 | 0.0% | 0.00% | – |
| Q3 2015 | $85,000 | -10.5% | 7,500 | 0.0% | 0.00% | – |
| Q2 2015 | $95,000 | +37.7% | 7,500 | 0.0% | 0.00% | – |
| Q1 2015 | $69,000 | -35.5% | 7,500 | 0.0% | 0.00% | – |
| Q4 2014 | $107,000 | +37.2% | 7,500 | 0.0% | 0.00% | – |
| Q3 2014 | $78,000 | -35.5% | 7,500 | 0.0% | 0.00% | – |
| Q2 2014 | $121,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |